Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 3Neoplasms 2Warts 1Urinary Bladder Neoplasms 1Spinal Cord Neoplasms 1Shock, Septic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion 1Papillomavirus Infections 1Liver Neoplasms 1Depression 1Carcinoma, Hepatocellular 1

Interventions

Saline Solution 1Methylene Blue 1Contraceptives, Oral 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Shock, Septic × Saline Solution × Clear all
NCT06005558 2024-07-05

Low Dose Versus High Dose Methylene Blue in Septic Patients

National Cancer Institute, Egypt

Phase 2/3 Completed
90 enrolled

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡